Ovizio

company

About

Ovizio develops digital holographic interferometric microscopy products.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€8M
Industries
3D Technology,Biotechnology,Life Science,Medical Device,Software
Founded date
Jan 1, 2010
Number Of Employee
11 - 50
Operating Status
Active

Ovizio develops digital holographic interferometric microscopy products. It builds 4D microscopic imaging devices and software based on digital holographic microscopy.

Ovizio offers oLine 4D, a research and development, and diagnostic desktop device that is used without specific sample preparation, as well as with automatic compensation of scratches or distortions on the sample support; iLine 4D, a multipurpose device for applications, such as inline or online flow monitoring or direct monitoring of cell cultures in bioreactors; and OsOne software for visualization, analysis, and archiving of images captured by the imaging devices. It also provides ILine F, a device that captures suspension cell culture process in real time; iLine M, an instrument that monitors cell confluence in multi layer vessels; iLine S, an equipment that monitors reproducibility of fragile cell; and QMod, a holographic and fluorescene microscopy.

Scientists in the areas of pharmaceutical and biotech research and development use the products of Ovizio. Philip Mathuis and Serge Jooris founded it in 2009, with its headquarters in Brussels in Belgium.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€8M
Ovizio has raised a total of €8M in funding over 2 rounds. Their latest funding was raised on Nov 16, 2015 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 16, 2015 Series Unknown €8M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Ovizio is funded by 1 investors. Nausicaa Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Nausicaa Ventures Series Unknown